- Trial site
Trial site location from the registry's own city and country. GeoNames (geonames.org).
Clinical trial site
Institute of Liver & Biliary Sciences (ILBS)
Institute of Liver & Biliary Sciences (ILBS) in New Delhi, National Capital Territory of Delhi, India is listed as a site for 34 registered clinical trials, 17 of them ongoing.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
This page covers the site record Institute of Liver & Biliary Sciences (ILBS) in New Delhi, National Capital Territory of Delhi, India: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.
Trials by phase
Registered trials that list this site, by trial phase. 34 trials counted.
-
Phase 2/3 3 trials
-
Not applicable 25 trials
-
Observational 6 trials
Trials by status
The registry's own status summary: Ongoing, Completed, Terminated or Other.
-
Ongoing 17 trials
-
Completed 7 trials
-
Other 10 trials
Trials over time
Trials registered with a start date in each year, 1990 onward, most recent years first.
Trials over time, by phase
- Phase 2/3
- Not applicable
- Observational
Top of scale: 14
Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 14 |
| 2024 | 4 |
| 2023 | 8 |
| 2022 | 1 |
| 2012 | 3 |
| 2010 | 3 |
2026 is partial: trials registered with a 2026 start date so far, not a full year
Recent trials
The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.
Showing 5 of 34 trials.
Conditions studied
The specific conditions of the trials that list this site, most trials first.
Showing 5 of 18 conditions.